Indonesia University
ui.ac.idTotal trials
440
Active
49
Phase 3
38
Total enrollment
58,257
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 13 of 13 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Esomeprazole | — | — | — | — | 2 | ||
| Propolis drops | — | — | — | — | — | 1 | |
| Vonoprazan 20 mg | — | — | — | — | — | 1 | |
| Simvastatin 40mg | — | — | — | — | — | 2 | |
| Mesenchymal Stromal/Stem Cells-Derived Exosomes (Exo-HWS + 1 vial Exo-HUVEC) Therapy | — | — | — | — | — | 1 | |
| Mesenchymal Stromal/Stem Cells-Derived Exosomes (Exo-HWS ) Therapy | — | — | — | — | — | 1 | |
| uc-msc secretome intra cavernous | — | — | — | — | — | 1 | |
| Triple combination cream | — | — | — | — | — | 1 | |
| Oral Vitamin C | — | — | — | — | — | 1 | |
| injection of local anesthesia solution | — | — | — | — | — | 1 | |
| Injection of normal saline | — | — | — | — | — | 1 | |
| Concentrated secretome Injection 3 mL | — | — | — | — | — | 1 | |
| Concentrated secretome Injection 3 mL with addition of TGF Beta 3 | — | — | — | — | — | 1 |
Next readouts
- 2025-03
- 2025-04-25
- 2025-05
- 2025-05-26
- 2025-06-30
- 2025-12-31
- 2025-12-31
- 2026-04-01
- 2026-05-14
Top conditions
- Obesity10
- Sepsis7
- Surgery7
- Quality of Life6
- Oxidative Stress6
- Acne Vulgaris6
- Anesthesia6
- Diabetes Mellitus6
Frequently asked questions about Indonesia University
- How many clinical trials does Indonesia University have on ClinicalTrials.gov?
- Indonesia University is listed as the lead sponsor on 440 clinical trials in ClinicalTrials.gov, 49 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Indonesia University's trials are in Phase 3?
- 38 of Indonesia University's trials are in Phase 3, spread across 13 active drug programs.
- What therapeutic areas does Indonesia University focus on?
- Indonesia University's most-studied conditions on ClinicalTrials.gov are Obesity, Sepsis, Surgery, Quality of Life, Oxidative Stress.
- When are Indonesia University's next clinical trial readouts?
- Indonesia University has 9 upcoming primary-completion readouts tracked here; the soonest is “Effect of Vitamin C Supplementation in Corneal Endothelial Damage in Phacoemulsification of Patients with Hard Cataracts”, expected around 2025-03.